Company Name | GEXVal Inc. |
Mailing Address | 12-09 Shonan iPark 2-26-1 Muraoka Higashi, Fujisawa-shi, Kanagawa, 251-8555, Japan |
Establishment | February 1, 2018 |
Capital | JPY 10,000,000 (as of December 2024) |
Representative | Juran Kato |
Board/Employee | 12 (as of May 2025) |
Business | Research and development of drugs targeting rare and untreatable diseases |
Major Shareholders | Mitsubishi UFJ Capital Co Ltd eBEST INVESTMENT & SECURITIES Co Ltd YK VENTURE PARTNERS Co Ltd Alfresa Holdings Corporation TNP Threads Of Light Corporation Takeda Pharmaceutical Co Ltd Juran Kato Axil Capital Advisors KK |
Subsidiary | GEXVal AU Pty Ltd L 2 169 Pirie St, Adelaide, SA 5000, Australia |
